GUSHENGTANG plans to spend up to 300 million yuan for a buyback

Mainland Chinese traditional medicine chain GUSHENGTANG (02273.HK) announced that the board of directors has resolved today (29th) to exercise the repurchase authorization, utilizing internal resources to repurchase shares in the open market for a total price of up to 300 million yuan, with the period starting from today until the conclusion of the company's next annual general meeting, or until the expiration of any applicable laws or the company's articles of association that require the company to hold the next annual general meeting, or until the authorization granted by this resolution is revoked or amended by a ordinary resolution passed at the shareholders' meeting